Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SELP | P16109 | 2/20 | 0.62 |
| ▸ | SELL | P14151 | 1/20 | 0.62 |
| ▸ | MAG | P20916 | 9/20 | 0.62 |
| ▸ | SIGLEC7 | Q9Y286 | 6/20 | 0.60 |
| ▸ | NANP | Q8TBE9 | 1/20 | 0.52 |
| ▸ | SELE | P16581 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29396615 | 1.00 | SELP (0.62) | SELPSELLMAGSIGLEC7NANP | |
| SCHEMBL17300130 | 1.00 | SELP (0.62) | SELPSELLMAGSIGLEC7NANP | |
| SCHEMBL29533149 | 0.95 | SELL (0.62) | SELPSELLMAGSIGLEC7NANP | |
| SCHEMBL29425234 | 0.95 | SELL (0.62) | SELPSELLMAGSIGLEC7NANP | |
| SCHEMBL29454806 | 0.95 | SIGLEC7 (0.66) | SELPSELLMAGSIGLEC7NANP | |
| SCHEMBL29393136 | 0.95 | SIGLEC7 (0.66) | SELPSELLMAGSIGLEC7NANP | |
| SCHEMBL29355980 | 0.95 | SIGLEC7 (0.66) | SELPSELLMAGSIGLEC7NANP | |
| SCHEMBL30483871 | 0.94 | SIGLEC7 (0.65) | SELPSELLMAGSIGLEC7NANP | |
| SCHEMBL29732819 | 0.94 | SIGLEC7 (0.65) | SELPSELLMAGSIGLEC7NANP | |
| SCHEMBL29432515 | 0.94 | SELL (0.68) | SELPSELLMAGSIGLEC7NANP |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 277 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4742900-A1 | METHOD TO IMPROVE A PLANT'S GROWTH, DEVELOPMENT AND RESISTANCE TO (A)BIOTIC STRESS | Globachem NV (BE) | 2026-05-20 | — | — | EP | claimed |
| EP-4725503-A2 | CHIMERIC ANTIGEN RECEPTORS TARGETING CANCER | University Of Southern California (US) | 2026-04-15 | — | — | EP | claimed |
| WO-2025217472-A1 | IMMUNOREGULATORY ANTIGEN-PRESENTING VESICLES | CALIFORNIA INSTITUTE OF TECHNOLOGY (US) | 2025-10-16 | — | — | WO | claimed |
| EP-4577234-A1 | IMPROVING IMMUNE CELL FUNCTION | Kite Pharma, Inc. (US) | 2025-07-02 | — | — | EP | claimed |
| WO-2025012479-A1 | METHOD TO IMPROVE A PLANT'S GROWTH, DEVELOPMENT AND RESISTANCE TO (A)BIOTIC STRESS | INBIOSE N.V. (BE) | 2025-01-16 | — | — | WO | claimed |
| WO-2024044670-A1 | IMPROVING IMMUNE CELL FUNCTION | KITE PHARMA, INC. (US) | 2024-02-29 | — | — | WO | claimed |
| US-20230357717-A1 | CELL SECRETED MINIBODIES AND USES THEREOF | NOVARTIS AG (CH) | 2023-11-09 | — | — | US | claimed |
| EP-4196149-A1 | IMPROVING IMMUNE CELL FUNCTION | Kite Pharma, Inc. (US) | 2023-06-21 | — | — | EP | claimed |
| EP-4136228-A1 | THERMAL CONTROL OF T-CELL IMMUNOTHERAPY THROUGH MOLECULAR AND PHYSICAL ACTUATION | California Institute of Technology (US) | 2023-02-22 | — | — | EP | claimed |
| EP-4121079-A1 | NOVEL ANTIGEN BINDING DOMAINS AND SYNTHETIC ANTIGEN RECEPTORS INCORPORATING THE SAME | UNIVERSITY OF SOUTHERN CALIFORNIA (US) | 2023-01-25 | — | — | EP | claimed |
| US-11549099-B2 | Cell secreted minibodies and uses thereof | NOVARTIS AG (CH) | 2023-01-10 | — | — | US | claimed |
| EP-4097144-A1 | GENOME ENGINEERING THE HUMAN IMMUNOGLOBULIN LOCUS TO EXPRESS RECOMBINANT BINDING DOMAIN MOLECULES | University of Southern California (US) | 2022-12-07 | — | — | EP | claimed |
| WO-2022036041-A1 | IMPROVING IMMUNE CELL FUNCTION | KITE PHARMA, INC (US) | 2022-02-17 | — | — | WO | claimed |
| EP-4742902-A1 | METHOD TO IMPROVE A PLANT'S GROWTH, DEVELOPMENT AND RESISTANCE TO (A)BIOTIC STRESS | Globachem NV (BE) | 2026-05-20 | — | — | EP | disclosed |
| EP-4742899-A1 | METHOD TO IMPROVE A PLANT'S GROWTH, DEVELOPMENT AND RESISTANCE TO (A)BIOTIC STRESS | Globachem NV (BE) | 2026-05-20 | — | — | EP | disclosed |
| EP-4742901-A1 | METHOD TO IMPROVE A PLANT'S GROWTH, DEVELOPMENT AND RESISTANCE TO (A)BIOTIC STRESS | Globachem NV (BE) | 2026-05-20 | — | — | EP | disclosed |
| US-11254743-B2 | Anti-CD33 antibodies and methods of use thereof | ALECTOR LLC (US) | 2022-02-22 | — | — | US | disclosed |
| WO-2022036041-A1 | IMPROVING IMMUNE CELL FUNCTION | KITE PHARMA, INC (US) | 2022-02-17 | — | — | WO | disclosed |
| EP-3947432-A1 | CHIMERIC ANTIGEN RECEPTOR (CAR) MODULATION | Trustees of Boston University (US) | 2022-02-09 | — | — | EP | disclosed |
| EP-3942023-A1 | COMPOSITIONS AND METHODS FOR MODULATING METABOLIC REGULATORS OF T CELL PATHOGENICITY | The Broad Institute, Inc. (US) | 2022-01-26 | — | — | EP | disclosed |